TRUFIN PLC

M&A Activity • Dec 22, 2022

National Storage Mechanism | Additional information

RNS Number : 5417K

TruFin PLC

22 December 2022

22 December 2022

TruFin plc

("TruFin" or the "Company")

Rejected Indicative Offer for Oxygen

TruFin announces that it recently received a non-binding, indicative offer for Oxygen Finance Limited ("Oxygen") which values Oxygen at £26 million (the "Offer"). After considering the terms of the Offer, the Board of TruFin has rejected the Offer on the basis that it undervalues the business and prospects of Oxygen.

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.

For further information, please contact:

TruFin plc James van den Bergh, Chief Executive Officer Kam Bansil, Investor Relations	0203 743 1340 07779 229508
Liberum Capital Limited (Nominated Adviser and Corporate broker) Chris Clarke Edward Thomas	0203 100 2000

TruFin plc is the holding company for an operating group of companies that are niche lenders and early payment providers. TruFin Group combines the benefits of both the traditional relationship banking model and developments in the fintech sector. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website www.TruFin.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

OUPDGBDDDXDDGDB